Early vascular aging (EVA) and frailty represent two distinct phenotypes of accelerated biological aging. While both are associated with cardiovascular (CV) risk, their interrelationship and joint impact on long-term outcomes in the general population remain unclear.
This study aims to evaluate the associa...
H. Xie, F. Fan, J. Jia et al.· European Heart Journal· 0 citations
Combined hyperlipidemia (CHL) is common in clinical practice, yet operational definitions vary and current threshold-based approaches seldom incorporate high-density lipoprotein cholesterol (HDL-C) for phenotypic risk refinement.
To evaluate whether HDL-C stratification can improve risk-oriented characteri...
L. Wang, L. Zhang, Z. Liu et al.· European Heart Journal· 0 citations
Cardiovascular (CV) aging is a complex biological process driven by hemodynamic stress, metabolic dysregulation, and chronic inflammation. Traditional vascular aging models relying solely on arterial stiffness often fail to capture the systemic immuno-metabolic burden, leaving a gap in quantifying the residual CV...
H. Xie, F. Fan, J. Jia et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.